Shares of EXACT Sciences Corporation (NASDAQ:EXAS) ended Friday session in green amid volatile trading. The shares closed up +0.14 points or 0.73% at $19.40 with 3.90 million shares getting traded. Post opening the session at $19.00, the shares hit an intraday low of $18.99 and an intraday high of $19.77 and the price vacillated in this range throughout the day. The company has a market cap of $2.09 billion and the numbers of outstanding shares have been calculated to be 106.77 million shares.
EXACT Sciences Corporation (EXAS) on Sept. 16, 2016 announced that, in support of the Company’s continued growth plans, it granted restricted stock units covering a total of 24,119 shares of common stock to 18 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4). The Company is making this announcement as required by NASDAQ rules.
Shares of Opko Health Inc. (NASDAQ:OPK) ended Friday session in red amid volatile trading. The shares closed down -0.01 points or -0.10% at $10.21 with 3.88 million shares getting traded. Post opening the session at $10.16, the shares hit an intraday low of $10.15 and an intraday high of $10.32 and the price vacillated in this range throughout the day. The company has a market cap of $5.61 billion and the numbers of outstanding shares have been calculated to be 550.38 million shares.
Opko Health Inc. (OPK) on September 13, 2016 announced the appointment of Jane Pine Wood, Esq. as Chief Legal and Compliance Officer of its wholly owned subsidiary, BioReference Laboratories, effective October 1, 2016.
Ms. Wood is a nationally respected healthcare attorney who has been practicing law for 29 years. She specializes in laboratory regulatory and compliance matters, and has counseled more than 500 pathology groups and 350 clinical laboratories. For the past 28 years she has been with the multi-state law firm McDonald Hopkins LLC, where she is a member of the firm’s board of directors. Ms. Wood is a frequent speaker at national and state laboratory and pathology meetings, is a contributor to association publications and is regularly quoted in the national press. Ms. Wood graduated from the Vanderbilt University School of Law.
“We are delighted to welcome Jane to the BioReference Laboratories team. She has a distinguished legal career, having counseled a multitude of pathology practices and clinical laboratories across the country; she is considered one of the leading legal experts in the field. Her diverse experience and insight on matters impacting the diagnostics and laboratory industries will be of great value as we continue to deliver high quality diagnostic services to improve patient care,” said Gregory S. Henderson, M.D., Ph.D., President of BioReference Laboratories.